We’d love to hear your feedback on this activity. It helps us to continually improve our products.
University of Naples Federico II, Naples, Italy
Prof. Saccà is Associate Professor of Neurology at NSRO Department at the Federico II University of Naples, Italy. Prof. Saccà has his research focus on Myasthenia Gravis (RWE studies, international registries, clinical trials); Multiple Sclerosis (RWE studies, clinical trials, observational studies, neuropsychology); NMOSD (clinical trials); Ataxias (Neuroimaging, clinical trials, non-profit clinical trials, genetics); Migraine (pathogenesis). He participated in numerous clinical trials in Myasthenia Gravis, Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, Friedreich Ataxia, Spinocerebellar Ataxia type 2, Multiple System Atrophy, Parkinson’s Disease, Huntington’s Chorea.
Prof. Saccà discloses: Public speaking honoraria: Alexion, argenx, Biogen, Genpharm, Medpharma, Medison Pharma, Mylan, Neopharm Israel, Novartis, Roche, Sanofi and Zai Lab. Compensation for advisory boards: Alexion, Almirall, argenx, Astrazeneca, Avexis, Biogen, Dianthus, Lexeo Therapeutics, Novartis GmBh, Reata, Roche, Sandoz, Sanofi and Takeda. Consultation fees: Alexion, Dianthus, EPG Comunication Holding ltd, Medscape, PeerView and Vitaccess. Clinical trial principal investigator: Alexion, argenx, Dianthus, Immunovant, Lediant, Novartis, Prilenia, Remgen and Sanofi. Clinical Trial support: Almirall. Funding: Agenzia Italiana del Farmaco (AIFA), Associazione Italiana per la lotta alle Sindromi Atassiche (AISA), Freidreich Ataxia Research Alliance (FARA), Roche SpA and Tristan Allamby Research Fund (TARFfa).
University Hospital Zürich, Zürich, Switzerland
Prof. Weber is a Senior Physician at both the Department of Neurology and Department of Ophthalmology, as well as Supervisor at the Interdisciplinary Center for Vertigo and Neurological Visual Disorders at the University Hospital Zürich. He is a trained neurologist, certified in EMG, EEG and sleep medicine. He has been a lecturer in neuro-ophthalmology and neuro-otology since 2014. His research focus is on the development of diagnostic tests for patients with ocular motor and balance disorders based on eye movement measurements with state-of-the-art technology.
Prof. Weber discloses: Unpaid consultant and has received funding for travel from Otometric, a division of Natus. Principal investigator for research sponsored by Alexion Pharmaceuticals.
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Or use a
.Explore the latest in medical education and stay current in your field. Create a free account to track your learning.